<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-04-03" modified="2024-10-02" version="198" xmlns="http://uniprot.org/uniprot">
  <accession>Q9NZI8</accession>
  <accession>C9JT33</accession>
  <name>IF2B1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Insulin-like growth factor 2 mRNA-binding protein 1</fullName>
      <shortName>IGF2 mRNA-binding protein 1</shortName>
      <shortName>IMP-1</shortName>
      <shortName>IMP1</shortName>
    </recommendedName>
    <alternativeName>
      <fullName>Coding region determinant-binding protein</fullName>
      <shortName>CRD-BP</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>IGF-II mRNA-binding protein 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>VICKZ family member 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Zipcode-binding protein 1</fullName>
      <shortName>ZBP-1</shortName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">IGF2BP1</name>
    <name type="synonym">CRDBP</name>
    <name type="synonym">VICKZ1</name>
    <name type="synonym">ZBP1</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="submission" date="1999-10" db="EMBL/GenBank/DDBJ databases">
      <title>Ectopic expression of a KH-domain containing protein, highly homologous to both human IMP-1 and mouse CRD-BP, in benign and malignant mesenchymal tumors.</title>
      <authorList>
        <person name="Ioannidis P."/>
        <person name="Trangas T."/>
        <person name="Dimitriadis E."/>
        <person name="Samiotaki M."/>
        <person name="Panoutsakopoulos G."/>
        <person name="Kyriazoglou I."/>
        <person name="Voutzoulias S."/>
        <person name="Tsiapalis C.M."/>
        <person name="Kittas C."/>
        <person name="Agnantis N."/>
        <person name="Pandis N."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
  </reference>
  <reference key="2">
    <citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
      <title>A novel splice variant of the human IGF2 mRNA-binding protein 1 (IMP1/CRD-BP) isolated from human Hep3B hepatoma cells.</title>
      <authorList>
        <person name="Gong H.Y."/>
        <person name="Hu M.C."/>
        <person name="Wu J.L."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
    <scope>ALTERNATIVE SPLICING</scope>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
      <title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
      <authorList>
        <person name="Zody M.C."/>
        <person name="Garber M."/>
        <person name="Adams D.J."/>
        <person name="Sharpe T."/>
        <person name="Harrow J."/>
        <person name="Lupski J.R."/>
        <person name="Nicholson C."/>
        <person name="Searle S.M."/>
        <person name="Wilming L."/>
        <person name="Young S.K."/>
        <person name="Abouelleil A."/>
        <person name="Allen N.R."/>
        <person name="Bi W."/>
        <person name="Bloom T."/>
        <person name="Borowsky M.L."/>
        <person name="Bugalter B.E."/>
        <person name="Butler J."/>
        <person name="Chang J.L."/>
        <person name="Chen C.-K."/>
        <person name="Cook A."/>
        <person name="Corum B."/>
        <person name="Cuomo C.A."/>
        <person name="de Jong P.J."/>
        <person name="DeCaprio D."/>
        <person name="Dewar K."/>
        <person name="FitzGerald M."/>
        <person name="Gilbert J."/>
        <person name="Gibson R."/>
        <person name="Gnerre S."/>
        <person name="Goldstein S."/>
        <person name="Grafham D.V."/>
        <person name="Grocock R."/>
        <person name="Hafez N."/>
        <person name="Hagopian D.S."/>
        <person name="Hart E."/>
        <person name="Norman C.H."/>
        <person name="Humphray S."/>
        <person name="Jaffe D.B."/>
        <person name="Jones M."/>
        <person name="Kamal M."/>
        <person name="Khodiyar V.K."/>
        <person name="LaButti K."/>
        <person name="Laird G."/>
        <person name="Lehoczky J."/>
        <person name="Liu X."/>
        <person name="Lokyitsang T."/>
        <person name="Loveland J."/>
        <person name="Lui A."/>
        <person name="Macdonald P."/>
        <person name="Major J.E."/>
        <person name="Matthews L."/>
        <person name="Mauceli E."/>
        <person name="McCarroll S.A."/>
        <person name="Mihalev A.H."/>
        <person name="Mudge J."/>
        <person name="Nguyen C."/>
        <person name="Nicol R."/>
        <person name="O'Leary S.B."/>
        <person name="Osoegawa K."/>
        <person name="Schwartz D.C."/>
        <person name="Shaw-Smith C."/>
        <person name="Stankiewicz P."/>
        <person name="Steward C."/>
        <person name="Swarbreck D."/>
        <person name="Venkataraman V."/>
        <person name="Whittaker C.A."/>
        <person name="Yang X."/>
        <person name="Zimmer A.R."/>
        <person name="Bradley A."/>
        <person name="Hubbard T."/>
        <person name="Birren B.W."/>
        <person name="Rogers J."/>
        <person name="Lander E.S."/>
        <person name="Nusbaum C."/>
      </authorList>
      <dbReference type="PubMed" id="16625196"/>
      <dbReference type="DOI" id="10.1038/nature04689"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="1262" last="1270">
      <title>A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.</title>
      <authorList>
        <person name="Nielsen J."/>
        <person name="Christiansen J."/>
        <person name="Lykke-Andersen J."/>
        <person name="Johnsen A.H."/>
        <person name="Wewer U.M."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="9891060"/>
      <dbReference type="DOI" id="10.1128/mcb.19.2.1262"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 4-19; 26-35; 309-324 AND 508-525</scope>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>ASSOCIATION WITH A MRNP COMPLEX</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>GENE NOMENCLATURE</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2005" name="Nucleic Acids Res." volume="33" first="7074" last="7089">
      <title>The autoregulatory translational control element of poly(A)-binding protein mRNA forms a heteromeric ribonucleoprotein complex.</title>
      <authorList>
        <person name="Patel G.P."/>
        <person name="Ma S."/>
        <person name="Bag J."/>
      </authorList>
      <dbReference type="PubMed" id="16356927"/>
      <dbReference type="DOI" id="10.1093/nar/gki1014"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 27-35; 66-75 AND 510-524</scope>
    <scope>FUNCTION</scope>
    <scope>IDENTIFICATION IN A MRNP COMPLEX WITH PABPC1 AND CSDE1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1998" name="Nucleic Acids Res." volume="26" first="5036" last="5044">
      <title>The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.</title>
      <authorList>
        <person name="Doyle G.A."/>
        <person name="Betz N.A."/>
        <person name="Leeds P.F."/>
        <person name="Fleisig A.J."/>
        <person name="Prokipcak R.D."/>
        <person name="Ross J."/>
      </authorList>
      <dbReference type="PubMed" id="9801297"/>
      <dbReference type="DOI" id="10.1093/nar/26.22.5036"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 413-429 AND 510-524</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="9261" last="9269">
      <title>Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA.</title>
      <authorList>
        <person name="Prokipcak R.D."/>
        <person name="Herrick D.J."/>
        <person name="Ross J."/>
      </authorList>
      <dbReference type="PubMed" id="8132663"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(17)37102-8"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="29562" last="29569">
      <title>H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein.</title>
      <authorList>
        <person name="Runge S."/>
        <person name="Nielsen F.C."/>
        <person name="Nielsen J."/>
        <person name="Lykke-Andersen J."/>
        <person name="Wewer U.M."/>
        <person name="Christiansen J."/>
      </authorList>
      <dbReference type="PubMed" id="10875929"/>
      <dbReference type="DOI" id="10.1074/jbc.m001156200"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2003" name="Biochem. J." volume="376" first="383" last="391">
      <title>Nuclear transit of human zipcode-binding protein IMP1.</title>
      <authorList>
        <person name="Nielsen J."/>
        <person name="Adolph S.K."/>
        <person name="Rajpert-De Meyts E."/>
        <person name="Lykke-Andersen J."/>
        <person name="Koch G."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="12921532"/>
      <dbReference type="DOI" id="10.1042/bj20030943"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>MUTAGENESIS OF 213-LYS-GLU-214; 294-LYS-GLU-295 AND 423-LYS-LYS-424</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2004" name="EMBO J." volume="23" first="3346" last="3355">
      <title>Visualization of RNA-protein interactions in living cells: FMRP and IMP1 interact on mRNAs.</title>
      <authorList>
        <person name="Rackham O."/>
        <person name="Brown C.M."/>
      </authorList>
      <dbReference type="PubMed" id="15282548"/>
      <dbReference type="DOI" id="10.1038/sj.emboj.7600341"/>
    </citation>
    <scope>INTERACTION WITH FMR1</scope>
    <scope>RNA-BINDING</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2004" name="Nucleic Acids Res." volume="32" first="4368" last="4376">
      <title>Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability.</title>
      <authorList>
        <person name="Nielsen J."/>
        <person name="Kristensen M.A."/>
        <person name="Willemoes M."/>
        <person name="Nielsen F.C."/>
        <person name="Christiansen J."/>
      </authorList>
      <dbReference type="PubMed" id="15314207"/>
      <dbReference type="DOI" id="10.1093/nar/gkh754"/>
    </citation>
    <scope>SUBUNIT</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2005" name="Reproduction" volume="130" first="203" last="212">
      <title>Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.</title>
      <authorList>
        <person name="Hammer N.A."/>
        <person name="Hansen T.O."/>
        <person name="Byskov A.G."/>
        <person name="Rajpert-De Meyts E."/>
        <person name="Groendahl M.L."/>
        <person name="Bredkjaer H.E."/>
        <person name="Wewer U.M."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="16049158"/>
      <dbReference type="DOI" id="10.1530/rep.1.00664"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
      <title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
        <person name="Gnad F."/>
        <person name="Macek B."/>
        <person name="Kumar C."/>
        <person name="Mortensen P."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="17081983"/>
      <dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2006" name="EMBO J." volume="25" first="1456" last="1468">
      <title>RNA-binding IMPs promote cell adhesion and invadopodia formation.</title>
      <authorList>
        <person name="Vikesaa J."/>
        <person name="Hansen T.V."/>
        <person name="Joenson L."/>
        <person name="Borup R."/>
        <person name="Wewer U.M."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="16541107"/>
      <dbReference type="DOI" id="10.1038/sj.emboj.7601039"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2006" name="FEBS J." volume="273" first="5678" last="5690">
      <title>IMP1 interacts with poly(A)-binding protein (PABP) and the autoregulatory translational control element of PABP-mRNA through the KH III-IV domain.</title>
      <authorList>
        <person name="Patel G.P."/>
        <person name="Bag J."/>
      </authorList>
      <dbReference type="PubMed" id="17212783"/>
      <dbReference type="DOI" id="10.1111/j.1742-4658.2006.05556.x"/>
    </citation>
    <scope>HOMODIMERIZATION</scope>
    <scope>INTERACTION WITH PABPC1</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2006" name="J. Cell Biol." volume="175" first="527" last="534">
      <title>ZBP1 regulates mRNA stability during cellular stress.</title>
      <authorList>
        <person name="Stoehr N."/>
        <person name="Lederer M."/>
        <person name="Reinke C."/>
        <person name="Meyer S."/>
        <person name="Hatzfeld M."/>
        <person name="Singer R.H."/>
        <person name="Huettelmaier S."/>
      </authorList>
      <dbReference type="PubMed" id="17101699"/>
      <dbReference type="DOI" id="10.1083/jcb.200608071"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
      <title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
      <authorList>
        <person name="Beausoleil S.A."/>
        <person name="Villen J."/>
        <person name="Gerber S.A."/>
        <person name="Rush J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="16964243"/>
      <dbReference type="DOI" id="10.1038/nbt1240"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2006" name="Nature" volume="441" first="898" last="901">
      <title>CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signaling.</title>
      <authorList>
        <person name="Noubissi F.K."/>
        <person name="Elcheva I."/>
        <person name="Bhatia N."/>
        <person name="Shakoori A."/>
        <person name="Ougolkov A."/>
        <person name="Liu J."/>
        <person name="Minamoto T."/>
        <person name="Ross J."/>
        <person name="Fuchs S.Y."/>
        <person name="Spiegelman V.S."/>
      </authorList>
      <dbReference type="PubMed" id="16778892"/>
      <dbReference type="DOI" id="10.1038/nature04839"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>INDUCTION</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2007" name="Clin. Cancer Res." volume="13" first="434" last="442">
      <title>Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.</title>
      <authorList>
        <person name="Kato T."/>
        <person name="Hayama S."/>
        <person name="Yamabuki T."/>
        <person name="Ishikawa N."/>
        <person name="Miyamoto M."/>
        <person name="Ito T."/>
        <person name="Tsuchiya E."/>
        <person name="Kondo S."/>
        <person name="Nakamura Y."/>
        <person name="Daigo Y."/>
      </authorList>
      <dbReference type="PubMed" id="17255263"/>
      <dbReference type="DOI" id="10.1158/1078-0432.ccr-06-1297"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2007" name="EMBO Rep." volume="8" first="1052" last="1060">
      <title>Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells.</title>
      <authorList>
        <person name="Hoeck J."/>
        <person name="Weinmann L."/>
        <person name="Ender C."/>
        <person name="Ruedel S."/>
        <person name="Kremmer E."/>
        <person name="Raabe M."/>
        <person name="Urlaub H."/>
        <person name="Meister G."/>
      </authorList>
      <dbReference type="PubMed" id="17932509"/>
      <dbReference type="DOI" id="10.1038/sj.embor.7401088"/>
    </citation>
    <scope>INTERACTION WITH AGO1 AND AGO2</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="8340" last="8351">
      <title>ZBP2 facilitates binding of ZBP1 to beta-actin mRNA during transcription.</title>
      <authorList>
        <person name="Pan F."/>
        <person name="Huettelmaier S."/>
        <person name="Singer R.H."/>
        <person name="Gu W."/>
      </authorList>
      <dbReference type="PubMed" id="17893325"/>
      <dbReference type="DOI" id="10.1128/mcb.00972-07"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="798" last="811">
      <title>Molecular composition of IMP1 ribonucleoprotein granules.</title>
      <authorList>
        <person name="Joeson L."/>
        <person name="Vikesaa J."/>
        <person name="Krogh A."/>
        <person name="Nielsen L.K."/>
        <person name="Hansen T."/>
        <person name="Borup R."/>
        <person name="Johnsen A.H."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="17289661"/>
      <dbReference type="DOI" id="10.1074/mcp.m600346-mcp200"/>
    </citation>
    <scope>IDENTIFICATION IN A MRNP GRANULE COMPLEX</scope>
    <scope>INTERACTION WITH DHX9; ELAVL2; HNRNPA2B1; HNRNPC; HNRNPH1; HNRNPU; IGF2BP2; IGF2BP3; ILF2; PABPC1 AND YBX1</scope>
    <scope>RNA-BINDING</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2008" name="J. Virol." volume="82" first="5683" last="5692">
      <title>Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly.</title>
      <authorList>
        <person name="Zhou Y."/>
        <person name="Rong L."/>
        <person name="Lu J."/>
        <person name="Pan Q."/>
        <person name="Liang C."/>
      </authorList>
      <dbReference type="PubMed" id="18385235"/>
      <dbReference type="DOI" id="10.1128/jvi.00189-08"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH HIV-1 GAG</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2009" name="Mol. Cell" volume="35" first="240" last="246">
      <title>CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation.</title>
      <authorList>
        <person name="Elcheva I."/>
        <person name="Goswami S."/>
        <person name="Noubissi F.K."/>
        <person name="Spiegelman V.S."/>
      </authorList>
      <dbReference type="PubMed" id="19647520"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2009.06.007"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2009" name="RNA" volume="15" first="104" last="115">
      <title>Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.</title>
      <authorList>
        <person name="Weidensdorfer D."/>
        <person name="Stoehr N."/>
        <person name="Baude A."/>
        <person name="Lederer M."/>
        <person name="Koehn M."/>
        <person name="Schierhorn A."/>
        <person name="Buchmeier S."/>
        <person name="Wahle E."/>
        <person name="Huettelmaiery S."/>
      </authorList>
      <dbReference type="PubMed" id="19029303"/>
      <dbReference type="DOI" id="10.1261/rna.1175909"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>COMPONENT OF THE CRD-MEDIATED MRNA STABILIZATION COMPLEX</scope>
    <scope>IDENTIFICATION IN A MRNP COMPLEX</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2009" name="RNA" volume="15" first="1528" last="1542">
      <title>IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3'UTR.</title>
      <authorList>
        <person name="Weinlich S."/>
        <person name="Huettelmaier S."/>
        <person name="Schierhorn A."/>
        <person name="Behrens S.-E."/>
        <person name="Ostareck-Lederer A."/>
        <person name="Ostareck D.H."/>
      </authorList>
      <dbReference type="PubMed" id="19541769"/>
      <dbReference type="DOI" id="10.1261/rna.1578409"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>IDENTIFICATION IN A HCV IRES-MEDIATED TRANSLATION COMPLEX</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2012" name="Genes Dev." volume="26" first="176" last="189">
      <title>IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.</title>
      <authorList>
        <person name="Stohr N."/>
        <person name="Kohn M."/>
        <person name="Lederer M."/>
        <person name="Glass M."/>
        <person name="Reinke C."/>
        <person name="Singer R.H."/>
        <person name="Huttelmaier S."/>
      </authorList>
      <dbReference type="PubMed" id="22279049"/>
      <dbReference type="DOI" id="10.1101/gad.177642.111"/>
    </citation>
    <scope>FUNCTION IN CELL MIGRATION</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2013" name="Biol. Chem." volume="394" first="1077" last="1090">
      <title>Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains.</title>
      <authorList>
        <person name="Wachter K."/>
        <person name="Kohn M."/>
        <person name="Stohr N."/>
        <person name="Huttelmaier S."/>
      </authorList>
      <dbReference type="PubMed" id="23640942"/>
      <dbReference type="DOI" id="10.1515/hsz-2013-0111"/>
    </citation>
    <scope>INTERACTION WITH ELAVL1; DHX9 AND HNRNPU</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2013" name="Cell. Mol. Life Sci." volume="70" first="2657" last="2675">
      <title>Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?</title>
      <authorList>
        <person name="Bell J.L."/>
        <person name="Wachter K."/>
        <person name="Muhleck B."/>
        <person name="Pazaitis N."/>
        <person name="Kohn M."/>
        <person name="Lederer M."/>
        <person name="Huttelmaier S."/>
      </authorList>
      <dbReference type="PubMed" id="23069990"/>
      <dbReference type="DOI" id="10.1007/s00018-012-1186-z"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-73; SER-181 AND THR-528</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2018" name="Nat. Cell Biol." volume="20" first="285" last="295">
      <title>Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.</title>
      <authorList>
        <person name="Huang H."/>
        <person name="Weng H."/>
        <person name="Sun W."/>
        <person name="Qin X."/>
        <person name="Shi H."/>
        <person name="Wu H."/>
        <person name="Zhao B.S."/>
        <person name="Mesquita A."/>
        <person name="Liu C."/>
        <person name="Yuan C.L."/>
        <person name="Hu Y.C."/>
        <person name="Huettelmaier S."/>
        <person name="Skibbe J.R."/>
        <person name="Su R."/>
        <person name="Deng X."/>
        <person name="Dong L."/>
        <person name="Sun M."/>
        <person name="Li C."/>
        <person name="Nachtergaele S."/>
        <person name="Wang Y."/>
        <person name="Hu C."/>
        <person name="Ferchen K."/>
        <person name="Greis K.D."/>
        <person name="Jiang X."/>
        <person name="Wei M."/>
        <person name="Qu L."/>
        <person name="Guan J.L."/>
        <person name="He C."/>
        <person name="Yang J."/>
        <person name="Chen J."/>
      </authorList>
      <dbReference type="PubMed" id="29476152"/>
      <dbReference type="DOI" id="10.1038/s41556-018-0045-z"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH ELAVL1; MATR3 AND PABPC1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ROLE OF KH DOMAINS</scope>
    <scope>MUTAGENESIS OF LYS-213; LYS-294; 423-LYS-LYS-424 AND 505-LYS-GLY-506</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2020" name="Nat. Commun." volume="11" first="1685" last="1685">
      <title>An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis.</title>
      <authorList>
        <person name="Zhu S."/>
        <person name="Wang J.Z."/>
        <person name="Chen D."/>
        <person name="He Y.T."/>
        <person name="Meng N."/>
        <person name="Chen M."/>
        <person name="Lu R.X."/>
        <person name="Chen X.H."/>
        <person name="Zhang X.L."/>
        <person name="Yan G.R."/>
      </authorList>
      <dbReference type="PubMed" id="32245947"/>
      <dbReference type="DOI" id="10.1038/s41467-020-15403-9"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH RBRP; ELAVL1; MATR3 AND PABPC1</scope>
    <scope>MUTAGENESIS OF 423-LYS-LYS-424 AND 505-LYS-GLY-506</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2010" name="Genes Dev." volume="24" first="148" last="158">
      <title>ZBP1 recognition of beta-actin zipcode induces RNA looping.</title>
      <authorList>
        <person name="Chao J.A."/>
        <person name="Patskovsky Y."/>
        <person name="Patel V."/>
        <person name="Levy M."/>
        <person name="Almo S.C."/>
        <person name="Singer R.H."/>
      </authorList>
      <dbReference type="PubMed" id="20080952"/>
      <dbReference type="DOI" id="10.1101/gad.1862910"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 404-566</scope>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>DOMAIN</scope>
  </reference>
  <comment type="function">
    <text evidence="1 5 10 11 12 13 15 17 19 20 21 22 23 24 26 27 28 29">RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Preferentially binds to N6-methyladenosine (m6A)-containing mRNAs and increases their stability (PubMed:29476152, PubMed:32245947). Plays a direct role in the transport and translation of transcripts required for axonal regeneration in adult sensory neurons (By similarity). Regulates localized beta-actin/ACTB mRNA translation, a crucial process for cell polarity, cell migration and neurite outgrowth. Co-transcriptionally associates with the ACTB mRNA in the nucleus. This binding involves a conserved 54-nucleotide element in the ACTB mRNA 3'-UTR, known as the 'zipcode'. The RNP thus formed is exported to the cytoplasm, binds to a motor protein and is transported along the cytoskeleton to the cell periphery. During transport, prevents ACTB mRNA from being translated into protein. When the RNP complex reaches its destination near the plasma membrane, IGF2BP1 is phosphorylated. This releases the mRNA, allowing ribosomal 40S and 60S subunits to assemble and initiate ACTB protein synthesis. Monomeric ACTB then assembles into the subcortical actin cytoskeleton (By similarity). During neuronal development, key regulator of neurite outgrowth, growth cone guidance and neuronal cell migration, presumably through the spatiotemporal fine tuning of protein synthesis, such as that of ACTB (By similarity). May regulate mRNA transport to activated synapses (By similarity). Binds to and stabilizes ABCB1/MDR-1 mRNA (By similarity). During interstinal wound repair, interacts with and stabilizes PTGS2 transcript. PTGS2 mRNA stabilization may be crucial for colonic mucosal wound healing (By similarity). Binds to the 3'-UTR of IGF2 mRNA by a mechanism of cooperative and sequential dimerization and regulates IGF2 mRNA subcellular localization and translation. Binds to MYC mRNA, in the coding region instability determinant (CRD) of the open reading frame (ORF), hence preventing MYC cleavage by endonucleases and possibly microRNA targeting to MYC-CRD (PubMed:29476152). Binding to MYC mRNA is enhanced by m6A-modification of the CRD (PubMed:29476152). Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells. Binds to the oncofetal H19 transcript and to the neuron-specific TAU mRNA and regulates their localizations. Binds to and stabilizes BTRC/FBW1A mRNA. Binds to the adenine-rich autoregulatory sequence (ARS) located in PABPC1 mRNA and represses its translation. PABPC1 mRNA-binding is stimulated by PABPC1 protein. Prevents BTRC/FBW1A mRNA degradation by disrupting microRNA-dependent interaction with AGO2. Promotes the directed movement of tumor-derived cells by fine-tuning intracellular signaling networks. Binds to MAPK4 3'-UTR and inhibits its translation. Interacts with PTEN transcript open reading frame (ORF) and prevents mRNA decay. This combined action on MAPK4 (down-regulation) and PTEN (up-regulation) antagonizes HSPB1 phosphorylation, consequently it prevents G-actin sequestration by phosphorylated HSPB1, allowing F-actin polymerization. Hence enhances the velocity of cell migration and stimulates directed cell migration by PTEN-modulated polarization. Interacts with Hepatitis C virus (HCV) 5'-UTR and 3'-UTR and specifically enhances translation at the HCV IRES, but not 5'-cap-dependent translation, possibly by recruiting eIF3. Interacts with HIV-1 GAG protein and blocks the formation of infectious HIV-1 particles. Reduces HIV-1 assembly by inhibiting viral RNA packaging, as well as assembly and processing of GAG protein on cellular membranes. During cellular stress, such as oxidative stress or heat shock, stabilizes target mRNAs that are recruited to stress granules, including CD44, IGF2, MAPK4, MYC, PTEN, RAPGEF2 and RPS6KA5 transcripts.</text>
  </comment>
  <comment type="subunit">
    <text evidence="7 8 10 14 16 18 19 20 21 25 26 27">Can form homodimers and heterodimers with IGF2BP1 and IGF2BP3. Component of the coding region determinant (CRD)-mediated complex, composed of DHX9, HNRNPU, IGF2BP1, SYNCRIP and YBX1. During HCV infection, identified in a HCV IRES-mediated translation complex, at least composed of EIF3C, IGF2BP1, RPS3 and HCV RNA-replicon. Interacts (via the KH domains) with HIV-1 GAG (via the second zinc finger motif of NC). Associates (via the RRM domains and KH domains) with HIV-1 particles. Identified in a mRNP complex, composed of at least DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2, PTBP2, STAU1, STAU2, SYNCRIP and YBX1. Identified in a IGF2BP1-dependent mRNP granule complex containing untranslated mRNAs. Interacts with DHX9, ELAVL2, HNRNPA2B1, HNRNPC, HNRNPH1, HNRNPU, IGF2BP2, ILF2, and YBX1. Interacts with FMR1. Component of a multisubunit autoregulatory RNP complex (ARC), at least composed of IGF2BP1, PABPC1 and CSDE1/UNR. Directly interacts with PABPC1 (PubMed:17212783, PubMed:29476152, PubMed:32245947). Component of a TAU mRNP complex, at least composed of IGF2BP1, ELAVL4 and G3BP. Interacts with ELAVL4 in an RNA-dependent manner. Associates with microtubules and polysomes. Interacts with AGO1 and AGO2. Interacts with ELAVL1 and MATR3 (PubMed:29476152, PubMed:32245947). Interacts (via KH3 and KH4 domains) with SEPIN14P20 peptide RBRP; the interaction results in increased binding of IGF2BP1 to N6-methyladenosine (m6A)-containing mRNAs (PubMed:32245947).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1053892">
      <id>Q9NZI8</id>
    </interactant>
    <interactant intactId="EBI-1053596">
      <id>Q13627</id>
      <label>DYRK1A</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1053892">
      <id>Q9NZI8</id>
    </interactant>
    <interactant intactId="EBI-1055820">
      <id>Q9HCE1</id>
      <label>MOV10</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1053892">
      <id>Q9NZI8</id>
    </interactant>
    <interactant intactId="EBI-358174">
      <id>O95793</id>
      <label>STAU1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>7</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1053892">
      <id>Q9NZI8</id>
    </interactant>
    <interactant intactId="EBI-1216533">
      <id>Q8VDS3</id>
      <label>Cbx7</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location>Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Cytoplasm</location>
      <location>Perinuclear region</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="26">Cytoplasm</location>
      <location evidence="26">P-body</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="26">Cytoplasm</location>
      <location evidence="26">Stress granule</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Cell projection</location>
      <location>Lamellipodium</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="1">Cell projection</location>
      <location evidence="1">Dendrite</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="1">Cell projection</location>
      <location evidence="1">Dendritic spine</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Cell projection</location>
      <location>Growth cone</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="1">Cell projection</location>
      <location evidence="1">Filopodium</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="1">Cell projection</location>
      <location evidence="1">Axon</location>
    </subcellularLocation>
    <text evidence="1">In the nucleus, located in discrete foci, coinciding with the sites of ACTB transcription (By similarity). In the cytoplasm, localizes in cytoplasmic mRNP granules. Colocalizes with microtubules in growth cone filopodia and along neurites in neuronal cells (By similarity). Cytoplasmic colocalization with ACTB mRNA is partially lost at the cell periphery, suggesting release of the transcript. In neuronal processes, exhibits fast retrograde and anterograde movements, when associated with ACTB mRNA; this motility is lost when the association is inhibited (By similarity). In hippocampal neurons, predominantly located within dendrites, particularly at dendritic branching points in young cells, compared to axons (By similarity). In axons, predominantly found in axonal branches and their growth cones (By similarity). In motile cells, such as migrating fibroblasts, localizes to leading edges where it colocalizes with microtubules and microfilaments and to retracting tails (By similarity). Dendritic levels are regulated by neuronal activity and glutaminergic signals: they are increased by KCl-induced depolarization, which induces rapid efflux from the cell body into dendrites, and decreased by the NMDA receptor agonist (By similarity). In motile cells, transported towards the leading edge into the cortical region of the lamellipodia where it is connected to microfilaments (By similarity). In response to cellular stress, such as oxidative stress or heat shock, recruited to stress granules, but not to processing bodies.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>Q9NZI8-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>Q9NZI8-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_045366"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="6 9 15 29">Mainly expressed in the embryo, including in fetal liver, fetal lung, fetal kidney, fetal thymus (at protein level). Also expressed follicles of ovary, as well as in gonocytes of testis, spermatogonia, semen, oocytes and placenta (at protein level). Expressed in various cancers, including testis and lung cancers (at protein level), as well as kidney, prostate and trachea cancers.</text>
  </comment>
  <comment type="induction">
    <text evidence="12">May be up-regulated in response to CTNNB1/beta-catenin activation.</text>
  </comment>
  <comment type="domain">
    <text evidence="23 26">Domains KH3 and KH4 are the major RNA-binding modules, although KH1 and KH2 may also contribute (PubMed:29476152). KH1 and KH2, and possibly KH3 and KH4, promote the formation of higher ordered protein-RNA complexes, which may be essential for IGF2BP1 cytoplasmic retention. KH domains are required for RNA-dependent homo- and heterooligomerization and for localization to stress granules. KH3 and KH4 mediate association with the cytoskeleton. Two nuclear export signals (NES) have been identified in KH2 and KH4 domains, respectively. Only KH2 NES is XPO1-dependent. Both NES may be redundant, since individual in vitro mutations do not affect subcellular location of the full-length protein. The 4 KH domains are important to suppress HIV-1 infectivity.</text>
  </comment>
  <comment type="PTM">
    <text evidence="1">Phosphorylated. Phosphorylation may impair association with ACTB mRNA and hence abolishes translational repression (By similarity).</text>
  </comment>
  <comment type="similarity">
    <text evidence="31">Belongs to the RRM IMP/VICKZ family.</text>
  </comment>
  <comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
    <link uri="https://atlasgeneticsoncology.org/gene/40969/IGF2BP1"/>
  </comment>
  <dbReference type="EMBL" id="AF198254">
    <property type="protein sequence ID" value="AAF37203.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="DQ227344">
    <property type="protein sequence ID" value="ABB46294.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC091133">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC105030">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS11543.1">
    <molecule id="Q9NZI8-1"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS54138.1">
    <molecule id="Q9NZI8-2"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001153895.1">
    <molecule id="Q9NZI8-2"/>
    <property type="nucleotide sequence ID" value="NM_001160423.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_006537.3">
    <molecule id="Q9NZI8-1"/>
    <property type="nucleotide sequence ID" value="NM_006546.3"/>
  </dbReference>
  <dbReference type="PDB" id="3KRM">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.75 A"/>
    <property type="chains" value="A/B/C=404-566"/>
  </dbReference>
  <dbReference type="PDB" id="6QEY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=194-369"/>
  </dbReference>
  <dbReference type="PDBsum" id="3KRM"/>
  <dbReference type="PDBsum" id="6QEY"/>
  <dbReference type="AlphaFoldDB" id="Q9NZI8"/>
  <dbReference type="SMR" id="Q9NZI8"/>
  <dbReference type="BioGRID" id="115886">
    <property type="interactions" value="512"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-1080">
    <property type="entry name" value="CRD-mediated mRNA stability complex"/>
  </dbReference>
  <dbReference type="CORUM" id="Q9NZI8"/>
  <dbReference type="DIP" id="DIP-38139N"/>
  <dbReference type="IntAct" id="Q9NZI8">
    <property type="interactions" value="190"/>
  </dbReference>
  <dbReference type="MINT" id="Q9NZI8"/>
  <dbReference type="STRING" id="9606.ENSP00000290341"/>
  <dbReference type="GlyGen" id="Q9NZI8">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q9NZI8"/>
  <dbReference type="PhosphoSitePlus" id="Q9NZI8"/>
  <dbReference type="SwissPalm" id="Q9NZI8"/>
  <dbReference type="BioMuta" id="IGF2BP1"/>
  <dbReference type="DMDM" id="296434536"/>
  <dbReference type="jPOST" id="Q9NZI8"/>
  <dbReference type="MassIVE" id="Q9NZI8"/>
  <dbReference type="PaxDb" id="9606-ENSP00000290341"/>
  <dbReference type="PeptideAtlas" id="Q9NZI8"/>
  <dbReference type="ProteomicsDB" id="11549"/>
  <dbReference type="ProteomicsDB" id="83410">
    <molecule id="Q9NZI8-1"/>
  </dbReference>
  <dbReference type="Pumba" id="Q9NZI8"/>
  <dbReference type="TopDownProteomics" id="Q9NZI8-1">
    <molecule id="Q9NZI8-1"/>
  </dbReference>
  <dbReference type="Antibodypedia" id="17915">
    <property type="antibodies" value="372 antibodies from 37 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="10642"/>
  <dbReference type="Ensembl" id="ENST00000290341.8">
    <molecule id="Q9NZI8-1"/>
    <property type="protein sequence ID" value="ENSP00000290341.3"/>
    <property type="gene ID" value="ENSG00000159217.10"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000431824.2">
    <molecule id="Q9NZI8-2"/>
    <property type="protein sequence ID" value="ENSP00000389135.2"/>
    <property type="gene ID" value="ENSG00000159217.10"/>
  </dbReference>
  <dbReference type="GeneID" id="10642"/>
  <dbReference type="KEGG" id="hsa:10642"/>
  <dbReference type="MANE-Select" id="ENST00000290341.8">
    <property type="protein sequence ID" value="ENSP00000290341.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_006546.4"/>
    <property type="RefSeq protein sequence ID" value="NP_006537.3"/>
  </dbReference>
  <dbReference type="UCSC" id="uc002iom.4">
    <molecule id="Q9NZI8-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:28866"/>
  <dbReference type="CTD" id="10642"/>
  <dbReference type="DisGeNET" id="10642"/>
  <dbReference type="GeneCards" id="IGF2BP1"/>
  <dbReference type="HGNC" id="HGNC:28866">
    <property type="gene designation" value="IGF2BP1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000159217">
    <property type="expression patterns" value="Group enriched (placenta, testis)"/>
  </dbReference>
  <dbReference type="MIM" id="608288">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q9NZI8"/>
  <dbReference type="OpenTargets" id="ENSG00000159217"/>
  <dbReference type="PharmGKB" id="PA143485501"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000159217"/>
  <dbReference type="eggNOG" id="KOG2193">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000160427"/>
  <dbReference type="HOGENOM" id="CLU_020744_1_0_1"/>
  <dbReference type="InParanoid" id="Q9NZI8"/>
  <dbReference type="OMA" id="YIPDEQT"/>
  <dbReference type="OrthoDB" id="3035007at2759"/>
  <dbReference type="PhylomeDB" id="Q9NZI8"/>
  <dbReference type="TreeFam" id="TF320229"/>
  <dbReference type="PathwayCommons" id="Q9NZI8"/>
  <dbReference type="Reactome" id="R-HSA-428359">
    <property type="pathway name" value="Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5687128">
    <property type="pathway name" value="MAPK6/MAPK4 signaling"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q9NZI8"/>
  <dbReference type="SIGNOR" id="Q9NZI8"/>
  <dbReference type="BioGRID-ORCS" id="10642">
    <property type="hits" value="35 hits in 1167 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="IGF2BP1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q9NZI8"/>
  <dbReference type="GeneWiki" id="IGF2BP1"/>
  <dbReference type="GenomeRNAi" id="10642"/>
  <dbReference type="Pharos" id="Q9NZI8">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q9NZI8"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 17"/>
  </dbReference>
  <dbReference type="RNAct" id="Q9NZI8">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000159217">
    <property type="expression patterns" value="Expressed in male germ line stem cell (sensu Vertebrata) in testis and 127 other cell types or tissues"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070937">
    <property type="term" value="C:CRD-mediated mRNA stability complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010494">
    <property type="term" value="C:cytoplasmic stress granule"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043197">
    <property type="term" value="C:dendritic spine"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030175">
    <property type="term" value="C:filopodium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030426">
    <property type="term" value="C:growth cone"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030027">
    <property type="term" value="C:lamellipodium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043025">
    <property type="term" value="C:neuronal cell body"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000932">
    <property type="term" value="C:P-body"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0048471">
    <property type="term" value="C:perinuclear region of cytoplasm"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990904">
    <property type="term" value="C:ribonucleoprotein complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003730">
    <property type="term" value="F:mRNA 3'-UTR binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0048027">
    <property type="term" value="F:mRNA 5'-UTR binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003729">
    <property type="term" value="F:mRNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990247">
    <property type="term" value="F:N6-methyladenosine-containing RNA reader activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045182">
    <property type="term" value="F:translation regulator activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070934">
    <property type="term" value="P:CRD-mediated mRNA stabilization"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140059">
    <property type="term" value="P:dendrite arborization"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051028">
    <property type="term" value="P:mRNA transport"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:1900152">
    <property type="term" value="P:negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="ComplexPortal"/>
  </dbReference>
  <dbReference type="GO" id="GO:0017148">
    <property type="term" value="P:negative regulation of translation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007399">
    <property type="term" value="P:nervous system development"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097150">
    <property type="term" value="P:neuronal stem cell population maintenance"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0022013">
    <property type="term" value="P:pallium cell proliferation in forebrain"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:2000767">
    <property type="term" value="P:positive regulation of cytoplasmic translation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="ComplexPortal"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001817">
    <property type="term" value="P:regulation of cytokine production"/>
    <property type="evidence" value="ECO:0000305"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010610">
    <property type="term" value="P:regulation of mRNA stability involved in response to stress"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="CDD" id="cd22490">
    <property type="entry name" value="KH-I_IGF2BP1_rpt1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd22493">
    <property type="entry name" value="KH-I_IGF2BP1_rpt2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd22496">
    <property type="entry name" value="KH-I_IGF2BP1_rpt3"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd22499">
    <property type="entry name" value="KH-I_IGF2BP1_rpt4"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd12625">
    <property type="entry name" value="RRM1_IGF2BP1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd12628">
    <property type="entry name" value="RRM2_IGF2BP1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.310.210">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.70.330">
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.1370.10">
    <property type="entry name" value="K Homology domain, type 1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR034837">
    <property type="entry name" value="IGF2BP1_RRM1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR034842">
    <property type="entry name" value="IGF2BP1_RRM2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR004087">
    <property type="entry name" value="KH_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR004088">
    <property type="entry name" value="KH_dom_type_1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036612">
    <property type="entry name" value="KH_dom_type_1_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012677">
    <property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035979">
    <property type="entry name" value="RBD_domain_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000504">
    <property type="entry name" value="RRM_dom"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10288:SF92">
    <property type="entry name" value="INSULIN-LIKE GROWTH FACTOR 2 MRNA-BINDING PROTEIN 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10288">
    <property type="entry name" value="KH DOMAIN CONTAINING RNA BINDING PROTEIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00013">
    <property type="entry name" value="KH_1"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00076">
    <property type="entry name" value="RRM_1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SMART" id="SM00322">
    <property type="entry name" value="KH"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="SMART" id="SM00360">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54791">
    <property type="entry name" value="Eukaryotic type KH-domain (KH-domain type I)"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54928">
    <property type="entry name" value="RNA-binding domain, RBD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50084">
    <property type="entry name" value="KH_TYPE_1"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50102">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0966">Cell projection</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0509">mRNA transport</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0770">Synapse</keyword>
  <keyword id="KW-0810">Translation regulation</keyword>
  <keyword id="KW-0813">Transport</keyword>
  <feature type="chain" id="PRO_0000282533" description="Insulin-like growth factor 2 mRNA-binding protein 1">
    <location>
      <begin position="1"/>
      <end position="577"/>
    </location>
  </feature>
  <feature type="domain" description="RRM 1" evidence="3">
    <location>
      <begin position="2"/>
      <end position="75"/>
    </location>
  </feature>
  <feature type="domain" description="RRM 2" evidence="3">
    <location>
      <begin position="81"/>
      <end position="156"/>
    </location>
  </feature>
  <feature type="domain" description="KH 1" evidence="2">
    <location>
      <begin position="195"/>
      <end position="260"/>
    </location>
  </feature>
  <feature type="domain" description="KH 2" evidence="2">
    <location>
      <begin position="276"/>
      <end position="343"/>
    </location>
  </feature>
  <feature type="domain" description="KH 3" evidence="2">
    <location>
      <begin position="405"/>
      <end position="470"/>
    </location>
  </feature>
  <feature type="domain" description="KH 4" evidence="2">
    <location>
      <begin position="487"/>
      <end position="553"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="4">
    <location>
      <begin position="160"/>
      <end position="190"/>
    </location>
  </feature>
  <feature type="region of interest" description="Necessary for interaction with ELAVL4 and binding to TAU mRNA" evidence="1">
    <location>
      <begin position="187"/>
      <end position="570"/>
    </location>
  </feature>
  <feature type="region of interest" description="Sufficient for nuclear export">
    <location>
      <begin position="310"/>
      <end position="324"/>
    </location>
  </feature>
  <feature type="region of interest" description="Sufficient for nuclear export">
    <location>
      <begin position="485"/>
      <end position="495"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="35">
    <location>
      <position position="12"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="35">
    <location>
      <position position="73"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 33 34 35">
    <location>
      <position position="181"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="35">
    <location>
      <position position="528"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_045366" description="In isoform 2." evidence="30">
    <location>
      <begin position="135"/>
      <end position="273"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="50-fold decrease in RNA-binding affinity, decreased location in cytoplasmic RNP, increased nuclear location; when associated with 294-E-L-295 and 423-E-L-424." evidence="6">
    <original>KE</original>
    <variation>EL</variation>
    <location>
      <begin position="213"/>
      <end position="214"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Partial reduction in interaction with m6A-modified mRNA; when associated with E-294." evidence="26">
    <original>K</original>
    <variation>E</variation>
    <location>
      <position position="213"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="50-fold decrease in RNA-binding affinity, decreased location in cytoplasmic RNP, increased nuclear location; when associated with 213-E-L-214 and 423-E-L-424." evidence="6">
    <original>KE</original>
    <variation>EL</variation>
    <location>
      <begin position="294"/>
      <end position="295"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Partial reduction in interaction with m6A-modified mRNA; when associated with E-213." evidence="26">
    <original>K</original>
    <variation>E</variation>
    <location>
      <position position="294"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of binding to RBPR and loss of interaction with m6A-modified mRNA; when associated with 505-E-E-506." evidence="26 27">
    <original>KK</original>
    <variation>EE</variation>
    <location>
      <begin position="423"/>
      <end position="424"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="50-fold decrease in RNA-binding affinity, decreased location in cytoplasmic RNP, increased nuclear location; when associated with 213-E-L-214 and 294-E-L-295." evidence="6">
    <original>KK</original>
    <variation>EL</variation>
    <location>
      <begin position="423"/>
      <end position="424"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of binding to RBPR and loss of interaction with m6A-modified mRNA; when associated with 423-E-E-424." evidence="26 27">
    <original>KG</original>
    <variation>EE</variation>
    <location>
      <begin position="505"/>
      <end position="506"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 4; AA sequence." evidence="31" ref="4">
    <location>
      <position position="10"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAF37203." evidence="31" ref="1">
    <original>I</original>
    <variation>T</variation>
    <location>
      <position position="281"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 4; AA sequence." evidence="31" ref="4">
    <location>
      <position position="320"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAF37203." evidence="31" ref="1">
    <original>I</original>
    <variation>T</variation>
    <location>
      <position position="365"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="198"/>
      <end position="203"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="204"/>
      <end position="206"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="207"/>
      <end position="211"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="213"/>
      <end position="215"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="216"/>
      <end position="225"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="228"/>
      <end position="232"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="241"/>
      <end position="248"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="250"/>
      <end position="270"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="279"/>
      <end position="284"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="285"/>
      <end position="292"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="294"/>
      <end position="296"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="297"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="309"/>
      <end position="312"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="315"/>
      <end position="317"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="324"/>
      <end position="331"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="333"/>
      <end position="361"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="406"/>
      <end position="413"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="414"/>
      <end position="416"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="417"/>
      <end position="421"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="423"/>
      <end position="425"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="426"/>
      <end position="435"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="438"/>
      <end position="441"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="450"/>
      <end position="458"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="460"/>
      <end position="476"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="488"/>
      <end position="495"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="496"/>
      <end position="498"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="499"/>
      <end position="503"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="505"/>
      <end position="507"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="508"/>
      <end position="517"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="520"/>
      <end position="522"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="533"/>
      <end position="541"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="543"/>
      <end position="560"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1"/>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00117"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="3">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00176"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="4">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="10875929"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="12921532"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="15282548"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="15314207"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="16049158"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="16356927"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="16541107"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="16778892"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="17101699"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="17212783"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="17255263"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="17289661"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="17893325"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="17932509"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="18385235"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="19029303"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="19541769"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="19647520"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="20080952"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="22279049"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="23640942"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="29476152"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="32245947"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="8132663"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="9891060"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="30">
    <source ref="2"/>
  </evidence>
  <evidence type="ECO:0000305" key="31"/>
  <evidence type="ECO:0007744" key="32">
    <source>
      <dbReference type="PubMed" id="16964243"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="33">
    <source>
      <dbReference type="PubMed" id="17081983"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="34">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="35">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="36">
    <source>
      <dbReference type="PDB" id="3KRM"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="37">
    <source>
      <dbReference type="PDB" id="6QEY"/>
    </source>
  </evidence>
  <sequence length="577" mass="63481" checksum="1D036AE5388D05FA" modified="2010-05-18" version="2">MNKLYIGNLNESVTPADLEKVFAEHKISYSGQFLVKSGYAFVDCPDEHWAMKAIETFSGKVELQGKRLEIEHSVPKKQRSRKIQIRNIPPQLRWEVLDSLLAQYGTVENCEQVNTESETAVVNVTYSNREQTRQAIMKLNGHQLENHALKVSYIPDEQIAQGPENGRRGGFGSRGQPRQGSPVAAGAPAKQQQVDIPLRLLVPTQYVGAIIGKEGATIRNITKQTQSKIDVHRKENAGAAEKAISVHSTPEGCSSACKMILEIMHKEAKDTKTADEVPLKILAHNNFVGRLIGKEGRNLKKVEQDTETKITISSLQDLTLYNPERTITVKGAIENCCRAEQEIMKKVREAYENDVAAMSLQSHLIPGLNLAAVGLFPASSSAVPPPPSSVTGAAPYSSFMQAPEQEMVQVFIPAQAVGAIIGKKGQHIKQLSRFASASIKIAPPETPDSKVRMVIITGPPEAQFKAQGRIYGKLKEENFFGPKEEVKLETHIRVPASAAGRVIGKGGKTVNELQNLTAAEVVVPRDQTPDENDQVIVKIIGHFYASQMAQRKIRDILAQVKQQHQKGQSNQAQARRK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>